These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 38485777)

  • 1. Our mission in the Japanese Society of Hypertension (JSH) Future Plan: a baton-connection from JSH Osaka 2023 to Fukuoka 2024.
    Node K; Tanaka A
    Hypertens Res; 2024 May; 47(5):1097-1098. PubMed ID: 38485777
    [No Abstract]   [Full Text] [Related]  

  • 2. [The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2004)].
    Saruta T
    Nihon Rinsho; 2005 Jun; 63(6):952-8. PubMed ID: 15948375
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Greeting Messages from President of Japanese Society of Hypertension (JSH) The challenge of JSH: moonshot for "Conquest of hypertension in Japan".
    Itoh H
    Hypertens Res; 2019 Jul; 42(7):925-927. PubMed ID: 31273348
    [No Abstract]   [Full Text] [Related]  

  • 4. Further promotion of "the JSH plan for the future" conscious of new normal after/with COVID-19: message from the new president of the Japanese Society of Hypertension.
    Rakugi H
    Hypertens Res; 2021 Jan; 44(1):4-6. PubMed ID: 33398127
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparison of questionnaire responses regarding awareness of Japanese Society of Hypertension guidelines for the management of hypertension between 2014 and 2019 in primary care.
    Kobayashi K; Hatori N; Sakai H; Furuki T; Miyakawa M; Tamura K; Sato K; Kanamori A
    Hypertens Res; 2021 Sep; 44(9):1147-1157. PubMed ID: 34253880
    [TBL] [Abstract][Full Text] [Related]  

  • 6. JSH Statement: Asahikawa declaration in promotion of diversity by the Japanese society of hypertension-the JSH Asahikawa declaration.
    Nakamura S; Hasebe N; Yatabe M; Kishi T; Ishida M; Ichihara A; Node K; Ishimitsu T; Itoh H; Ito M; Ohishi M; Ohkubo T; Kai H; Kashihara N; Kario K; Saitoh S; Tsuchihashi T; Nishiyama A; Higaki J; Miura K; Rakugi H; Kawano Y; Tamura K; Yatabe T; Ohya Y; Ito S
    Hypertens Res; 2019 Oct; 42(10):1483-1484. PubMed ID: 30962519
    [No Abstract]   [Full Text] [Related]  

  • 7. Highlights of the 2019 Japanese Society of Hypertension Guidelines and perspectives on the management of Asian hypertensive patients.
    Hoshide S; Kario K; Tomitani N; Kabutoya T; Chia YC; Park S; Shin J; Turana Y; Tay JC; Buranakitjaroen P; Chen CH; Nailes J; Minh HV; Siddique S; Sison J; Soenarta AA; Sogunuru GP; Sukonthasarn A; Teo BW; Verma N; Zhang Y; Wang TD; Wang JG
    J Clin Hypertens (Greenwich); 2020 Mar; 22(3):369-377. PubMed ID: 31891452
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the Accuracy of ChatGPT in Answering Clinical Questions on the Japanese Society of Hypertension Guidelines.
    Kusunose K; Kashima S; Sata M
    Circ J; 2023 Jun; 87(7):1030-1033. PubMed ID: 37286486
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ninth Hypertension Research Award for authors of outstanding papers in Hypertension Research.
    Ishimitsu T
    Hypertens Res; 2018 Dec; 41(12):991-992. PubMed ID: 30514909
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Awareness of the Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2000) and compliance to its recommendations: surveys in 2000 and 2004.
    Ikeda N; Hasegawa T; Hasegawa T; Saito I; Saruta T
    J Hum Hypertens; 2006 Apr; 20(4):263-6. PubMed ID: 16355118
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trends in pharmacologic management of hypertension in Japan one year after the publication of the JSH 2000 guidelines. First Japanese Society of Hypertension.
    Saito I; Kawabe H; Tsujioka M; Hirose H; Shibata H
    Hypertens Res; 2002 Mar; 25(2):175-8. PubMed ID: 12047031
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dietary salt intake in Japan - past, present, and future.
    Tsuchihashi T
    Hypertens Res; 2022 May; 45(5):748-757. PubMed ID: 35296804
    [TBL] [Abstract][Full Text] [Related]  

  • 13. JSH Statement: Tokyo declaration promoting salt reduction by the Japanese Society of Hypertension-the JSH Tokyo declaration.
    Tsuchihashi T; Ishimitsu T; Ando K; Kusaka M; Ichihara A; Miura K; Kawano Y; Ishida T; Kumagai H; Sakima A; Takase H; Hayabuchi H; Itoh H
    Hypertens Res; 2020 Nov; 43(11):1133-1134. PubMed ID: 32475981
    [No Abstract]   [Full Text] [Related]  

  • 14. The 44th Annual Meeting of the Japanese Society for Apheresis.
    Abe T
    Ther Apher Dial; 2024 Aug; 28(4):485-488. PubMed ID: 38456251
    [No Abstract]   [Full Text] [Related]  

  • 15. Strategies for improving the treatment and control of hypertension in Japan.
    Sakima A; Matayoshi T; Arima H
    J Hum Hypertens; 2024 Jun; 38(6):510-515. PubMed ID: 35660794
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2009).
    Ogihara T; Kikuchi K; Matsuoka H; Fujita T; Higaki J; Horiuchi M; Imai Y; Imaizumi T; Ito S; Iwao H; Kario K; Kawano Y; Kim-Mitsuyama S; Kimura G; Matsubara H; Matsuura H; Naruse M; Saito I; Shimada K; Shimamoto K; Suzuki H; Takishita S; Tanahashi N; Tsuchihashi T; Uchiyama M; Ueda S; Ueshima H; Umemura S; Ishimitsu T; Rakugi H;
    Hypertens Res; 2009 Jan; 32(1):3-107. PubMed ID: 19300436
    [No Abstract]   [Full Text] [Related]  

  • 17. [The 65th Annual Meeting of the Japanese Society of Gastroenterology].
    Nagoshi S
    Nihon Shokakibyo Gakkai Zasshi; 2024; 121(6):431-433. PubMed ID: 38853011
    [No Abstract]   [Full Text] [Related]  

  • 18. [The Proceedings of the 112th Tohoku Regional Meeting of the Japanese Society of Neurology].
    Rinsho Shinkeigaku; 2024; 64(5):364-368. PubMed ID: 38797662
    [No Abstract]   [Full Text] [Related]  

  • 19. [The Japanese new guideline for the management of hypertension--background of its preparation and characteristics of the new guideline].
    Saruta T
    Nihon Rinsho; 2001 May; 59(5):837-40. PubMed ID: 11391979
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antihypertensive efficacy of olmesartan medoxomil and candesartan cilexetil in achieving 24-hour blood pressure reductions and ambulatory blood pressure goals.
    Brunner HR; Arakawa K
    Clin Drug Investig; 2006; 26(4):185-93. PubMed ID: 17163250
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.